Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J. Int J Nanomedicine. 2021;16:2735–2749. The authors have advised the Acknowledgment statement on page 2748 is incorrect. The acknowledgment section should read as follows: Acknowledgments The authors acknowledge the formulation for the docetaxel in...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9fc910278c4441028ff5b5728c9d220e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J. Int J Nanomedicine. 2021;16:2735–2749.
The authors have advised the Acknowledgment statement on page 2748 is incorrect. The acknowledgment section should read as follows:
Acknowledgments
The authors acknowledge the formulation for the docetaxel in Poly(2-oxazoline) micelles previously developed and published by the Kabanov lab with reference to Seo Y, Schulz A, Han Y, et al. Poly (2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors. Polym Adv Technol. 2015;26(7):837–850 (https://doi.org/10.1002/pat.3556).24 The current article reports the authors original research evaluating this polymeric micelle formulation of docetaxel in their own animal models. Dr Jing Gao wishes to acknowledge her time spent as a visiting scholar to the Kabanov lab at UNC-Chapel Hill from 2013-2014. This study was supported by Military Medical Innovation Project (16CXZ032), National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (No. 2018ZX09J18107-003, 2018ZX0 9721003-005-009) and NSFC projects (No. 81773278, 81702491).
Read the original article |
|---|